AM, R., SA, H., & G, P. (2008). Medications for the secondary prevention of ischaemic heart disease and heart failure are underutilized in dialysis patients. Internal Medicine Journal, 38(5), 361. https://doi.org/10.1111/j.1445-5994.2008.01649.x
Chicago Style (17th ed.) CitationAM, Ranchord, Harding SA, and Pidgeon G. "Medications for the Secondary Prevention of Ischaemic Heart Disease and Heart Failure Are Underutilized in Dialysis Patients." Internal Medicine Journal 38, no. 5 (2008): 361. https://doi.org/10.1111/j.1445-5994.2008.01649.x.
MLA (9th ed.) CitationAM, Ranchord, et al. "Medications for the Secondary Prevention of Ischaemic Heart Disease and Heart Failure Are Underutilized in Dialysis Patients." Internal Medicine Journal, vol. 38, no. 5, 2008, p. 361, https://doi.org/10.1111/j.1445-5994.2008.01649.x.